These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 22089926)

  • 21. Nesiritide: harmful or harmless?
    Dorsch MP; Rodgers JE
    Pharmacotherapy; 2006 Oct; 26(10):1465-78. PubMed ID: 16999657
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The rise and fall of Natrecor for congestive heart failure: implications for drug policy.
    Kesselheim AS; Fischer MA; Avorn J
    Health Aff (Millwood); 2006; 25(4):1095-102. PubMed ID: 16835191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Nesiritide in heart failure: commercial success or therapeutic advance?].
    Stampfli T; Perrier A
    Rev Med Suisse; 2006 Jan; 2(50):295-8. PubMed ID: 16503047
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment.
    Miller AH; Nazeer S; Pepe P; Estes B; Gorman A; Yancy CW
    Ann Emerg Med; 2008 May; 51(5):571-8. PubMed ID: 18304693
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversy and conflict in the treatment of acute decompensated heart failure: limited role for nesiritide.
    Noviasky JA
    Pharmacotherapy; 2007 May; 27(5):626-32. PubMed ID: 17461696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nesiritide use in pediatric patients with congestive heart failure.
    Feingold B; Law YM
    J Heart Lung Transplant; 2004 Dec; 23(12):1455-9. PubMed ID: 15607680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Re: Critical review and recommendations for nesiritide use in the Emergency Department.
    Levine M
    J Emerg Med; 2007 Feb; 32(2):207-8; author reply 208-9. PubMed ID: 17307636
    [No Abstract]   [Full Text] [Related]  

  • 28. Nesiritide in acute heart failure.
    de Moraes Barros GD; de Carvalho Leite CR
    Lancet; 2003 Sep; 362(9388):999. PubMed ID: 14511941
    [No Abstract]   [Full Text] [Related]  

  • 29. Does nesiritide reduce mortality and readmission in decompensated heart failure?
    Bernardo WM; Moreira FT
    Rev Assoc Med Bras (1992); 2012; 58(2):133-4. PubMed ID: 22569604
    [No Abstract]   [Full Text] [Related]  

  • 30. Hemodynamic effects and safety of nesiritide in neonates with heart failure.
    Simsic JM; Mahle WT; Cuadrado A; Kirshbom PM; Maher KO
    J Intensive Care Med; 2008; 23(6):389-95. PubMed ID: 18805856
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of nesiritide in critically ill children with biventricular dysfunction suffering from oliguria despite standard heart-failure management.
    Das BB; Koch J; Dimas V; Guleserian K; Nugent A
    Cardiol Young; 2016 Apr; 26(4):819-23. PubMed ID: 26694972
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Perioperative effects and safety of nesiritide following cardiac surgery in children.
    Simsic JM; Scheurer M; Tobias JD; Berkenbosch J; Schechter W; Madera F; Weinstein S; Michler RE
    J Intensive Care Med; 2006; 21(1):22-6. PubMed ID: 16698741
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BNP-mediated vasodilatation for dialysis-dependent patient with acute heart failure syndrome in the emergency department.
    Chandra A; Otero R; Freeman D; Cairns CB
    Ren Fail; 2008; 30(1):45-50. PubMed ID: 18197542
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nesiritide: trials and tribulations.
    Arora RR
    J Cardiovasc Pharmacol Ther; 2006 Sep; 11(3):165-9. PubMed ID: 17056828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nesiritide: the latest drug for treating heart failure.
    Fontana D
    Crit Care Nurse; 2006 Feb; 26(1):39-44, 46-7. PubMed ID: 16443809
    [No Abstract]   [Full Text] [Related]  

  • 36. Nesiritide: a unique therapeutic cardiac peptide.
    Rayburn BK; Bourge RC
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S25-31. PubMed ID: 12439359
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and safety of nesiritide in patients with acute decompensated heart failure.
    DeWald TA; Hernandez AF
    Expert Rev Cardiovasc Ther; 2010 Feb; 8(2):159-69. PubMed ID: 20136602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nesiritide: past, present, and future.
    Burger AJ; Burger MR
    Minerva Cardioangiol; 2005 Dec; 53(6):509-22. PubMed ID: 16333235
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of nesiritide (human b-type natriuretic peptide) and dobutamine on heart rate variability in decompensated heart failure.
    Aronson D; Burger AJ
    Am Heart J; 2004 Nov; 148(5):e16. PubMed ID: 15523294
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interaction between nesiritide and a heparin-coated pulmonary artery line during an infusion for decompensated heart failure.
    Baroletti SA; Wahlstrom HD
    Pharmacotherapy; 2004 Nov; 24(11):1634-7. PubMed ID: 15537565
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.